Bharat Biotech in tie-up with the US-based company FluGen and University of Wisconsin Madison to develop a vaccine named “Coro-Flu” to fight against COVID-19. CoroFlu will build on the backbone of FluGen’s flu vaccine candidate known as M2SR.
Click Here To Get Test Series For SBI PO 2020
The vaccine is being developed on the basis of FluGen’s flu vaccine candidate known as M2SR, a self-limited version of the influenza virus. It induces an immune response against the flu. The vaccine will be built by FluGen’s lab that inserts gene sequences from SARS-CoV-2, the novel coronavirus that causes the disease COVID-19 into M2SR so that the novel vaccine will also induce immunity against the coronavirus.
Important takeaways for all competitive exams:
Bondi Beach is one of Australia’s most recognisable and loved coastal destinations. Located just minutes…
As one of the all-time great WWE superstars, John Cena officially retired from in-ring competition…
The Indian Space Research Organisation (ISRO) has revealed plans for no less than seven space…
The Chakrashila Wildlife Sanctuary in Assam has recently come into focus due to successful community-led…
India’s presence in global motorsport technology received a major boost as MRF Tyres clinched the…
India's push towards meeting its increasing energy demands while ensuring long-term sustainability received a boost…